Evidence map›Paper›PMID 28454108›Full record

ArticleOncotarget2017

Telomere erosion in NF1 tumorigenesis.

Rhiannon E Jones, Julia W Grimstead, Ashni Sedani, Duncan Baird, Meena Upadhyaya

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Emerging therapeutic targets for neurofibromatosis type 1.Expert opinion on therapeutic targets · 2018
    Review
  5. Telomeres and genomic evolution.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rhiannon E JonesDivision of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Julia W GrimsteadDivision of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Ashni SedaniDivision of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Duncan BairdDivision of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Meena UpadhyayaDivision of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN, UK.
Cardiff University · GB

Funding

Cancer Research UK 18246
6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1; MIM# 162200) is a familial cancer syndrome that affects 1 in 3,500 individuals worldwide and is inherited in an autosomal dominant fashion. Malignant Peripheral Nerve Sheath Tumors (MPNSTs) represent a significant cause of morbidity and mortality in NF1 and currently there is no treatment or definite prognostic biomarkers for these tumors. Telomere shortening has been documented in numerous tumor types. Short dysfunctional telomeres are capable of fusion and it is considered that the ensuing genomic instability may facilitate clonal evolution and the progression to malignancy. To evaluate the potential role of telomere dysfunction in NF1-associated tumors, we undertook a comparative analysis of telomere length in samples derived from 10 cutaneous and 10 diffused plexiform neurofibromas, and 19 MPNSTs. Telomere length was determined using high-resolution Single Telomere Length Analysis (STELA). The mean Xp/Yp telomere length detected in MPNSTs, at 3.282 kb, was significantly shorter than that observed in both plexiform neurofibromas (5.793 kb; [p = 0.0006]) and cutaneous neurofibromas (6.141 kb; [p = 0.0007]). The telomere length distributions of MPNSTs were within the length-ranges in which telomere fusion is detected and that confer a poor prognosis in other tumor types. These data indicate that telomere length may play a role in driving genomic instability and clonal progression in NF1-associated MPNSTs.

Indexed as

CarcinogenesisComparative Genomic HybridizationHumansLoss of HeterozygosityNeoplasm GradingNeurilemmomaNeurofibromaNeurofibromatosis 1Neurofibromin 1TelomereTelomere ShorteningNeurofibromin 1cancergenetic instabilityMPNSTNF1telomere

Identifiers

PMID28454108
PMCPMC5522233
OpenAlexW2604194142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.